Page 143 - Mesenchymal Stem Cell-Derived Exosomes as an Emerging Paradigm for Regenerative Therapy and Nano-Medicine
P. 143

NEW AGE THERAPEUTICS



                                          "the power of s                 tem cells delivered"



                                                At the age of 80 years, and having

                                         experienced a spinal injury while hiking,

                                     which was followed by peripheral neuropathy

                                        for more than a year, I administered three

                                          courses of the ophthalmic drops of NAT's

                                         Exosome Therapy. Immediately following

                                       each course of treatment, the inflammation,

                                       neck and back pain, and loss of leg function
                                      that accompanied the spinal and neuropathy

                                            symptoms resolved to a noticeable and

                                        measurable degree. Each of the second and

                                      third courses of Exosome treatment added to

                                             improvements in pain resolution and

                                      functional mobility. Interestingly, and as an

                                      added observation, I noticed that I no longer

                                     needed my reading glasses for text reading or

                                         for computer work. Similarly, my hearing
                                     seems to have improved, as well. Another and


                                         wholly unexpected benefit were enhanced
                                        attention span while doing deep scientific

                                       literature investigations for my cancer and

                                     infectious disease work. I am looking forward

                                      to taking a fourth course of Exosomes, and to

                                                           the enhanced outcome.


                                        Richard C. Honour, PhD


                                        KENMORE, WA




                                            www.NewAgeCells.com
   138   139   140   141   142   143